Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Br J Haematol ; 192(5): 922-931, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33476407

RESUMO

Sickle cell anaemia (SCA) is a debilitating genetic haemoglobinopathy predominantly affecting the disenfranchised strata of society in Africa and the Americas. The most common pharmacological treatment for this disease is the administration of hydroxycarbamide (HC) for which questions remain regarding its mechanism of action, efficacy and long-term toxicity specifically in paediatric individuals. A multiplatform metabolomics approach was used to assess the metabolome of plasma samples from a population of children and adolescents with SCA with and without HC treatment along with non-SCA individuals. Fifty-three metabolites were identified by ultra-high performance liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) and 1 H nuclear magnetic resonance (NMR) with a predominance of membrane lipids, amino acids and organic acids. The partial least-squares discriminant analysis (PLS-DA) analysis allowed a clear discrimination between the different studied groups, revealing clear effects of the HC treatment in the patients' metabolome including rescue of specific metabolites to control levels. Increased creatine/creatinine levels under HC treatment suggests a possible increase in the arginine pool and increased NO synthesis, supporting existing models for HC action in SCA. The metabolomics results extend the current knowledge on the models for SCA pathophysiology including impairment of Lands' cycle and increased synthesis of sphingosine 1-phosphate. Putative novel biomarkers are suggested.


Assuntos
Anemia Falciforme/sangue , Antidrepanocíticos/uso terapêutico , Hidroxiureia/uso terapêutico , Metabolômica , Ácidos/sangue , Síndrome Torácica Aguda/etiologia , Adolescente , Aminoácidos/sangue , Anemia Falciforme/complicações , Anemia Falciforme/tratamento farmacológico , Antidrepanocíticos/farmacologia , Arteriopatias Oclusivas/etiologia , Biomarcadores , Butiratos/sangue , Criança , Cromatografia Líquida de Alta Pressão , Creatina/sangue , Creatinina/sangue , Feminino , Humanos , Hidroxiureia/farmacologia , Lisofosfolipídeos/sangue , Masculino , Espectrometria de Massas , Lipídeos de Membrana/sangue , Modelos Biológicos , Ressonância Magnética Nuclear Biomolecular , Esfingosina/análogos & derivados , Esfingosina/sangue
2.
Biomed Res Int ; 2019: 4978018, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31737665

RESUMO

Chronic exposure to arsenic (As), whether directly through the consumption of contaminated drinking water or indirectly through the daily intake of As-contaminated food, is a health threat for more than 150 million people worldwide. Epidemiological studies found an association between chronic consumption of As and several pathologies, the most common being cancer-related disorders. However, As consumption has also been associated with metabolic disorders that could lead to diverse pathologies, such as type 2 diabetes mellitus, nonalcoholic fatty liver disease, and obesity. Here, we used ultra-performance liquid chromatography (UPLC) coupled to electrospray ionization/quadrupole time-of-flight mass spectrometry (ESI-QToF) to assess the effect of chronic intergenerational As exposure on the lipid metabolism profiles of serum from 4-month-old Wistar rats exposed to As prenatally and also during early life in drinking water (3 ppm). Significant differences in the levels of certain identified lysophospholipids, phosphatidylcholines, and triglycerides were found between the exposed rats and the control groups, as well as between the sexes. Significantly increased lipid oxidation determined by the malondialdehyde (MDA) method was found in exposed rats compared with controls. Chronic intergenerational As exposure alters the rat lipidome, increases lipid oxidation, and dysregulates metabolic pathways, the factors associated with the chronic inflammation present in different diseases associated with chronic exposure to As (i.e., keratosis, Bowen's disease, and kidney, liver, bladder, and lung cancer).


Assuntos
Arsênio/toxicidade , Água Potável/efeitos adversos , Metabolismo dos Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Lisofosfolipídeos/sangue , Animais , Cromatografia Líquida de Alta Pressão , Água Potável/química , Humanos , Redes e Vias Metabólicas/efeitos dos fármacos , Ratos , Espectrometria de Massas por Ionização por Electrospray , Espectrometria de Massas em Tandem
3.
Mol Nutr Food Res ; 59(11): 2209-24, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26264677

RESUMO

SCOPE: Fumonisin (FB) occurs in maize and is an inhibitor of ceramide synthase (CerS). We determined the urinary FB1 (UFB1 ) and sphingoid base 1-phosphate levels in blood from women consuming maize in high and low FB exposure communities in Guatemala. METHODS AND RESULTS: FB1 intake was estimated using the UFB1 . Sphinganine 1-phosphate (Sa 1-P), sphingosine 1-phosphate (So 1-P), and the Sa 1-P/So 1-P ratio were determined in blood spots collected on absorbent paper at the same time as urine collection. In the first study, blood spots and urine were collected every 3 months (March 2011 to February 2012) from women living in low (Chimaltenango and Escuintla) and high (Jutiapa) FB exposure communities (1240 total recruits). The UFB1 , Sa 1-P/So 1-P ratio, and Sa 1-P/mL in blood spots were significantly higher in the high FB1 intake community compared to the low FB1 intake communities. The results were confirmed in a follow-up study (February 2013) involving 299 women living in low (Sacatepéquez) and high (Santa Rosa and Chiquimula) FB exposure communities. CONCLUSIONS: High levels of FB1 intake are correlated with changes in Sa 1-P and the Sa 1-P/So 1-P ratio in human blood in a manner consistent with FB1 inhibition of CerS.


Assuntos
Inibidores Enzimáticos/farmacologia , Fumonisinas/toxicidade , Oxirredutases/antagonistas & inibidores , Zea mays/microbiologia , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Eritrócitos/química , Feminino , Fumonisinas/urina , Humanos , Lisofosfolipídeos/sangue , Pessoa de Meia-Idade , Esfingosina/análogos & derivados , Esfingosina/sangue
4.
Lipids Health Dis ; 10: 170, 2011 Sep 28.
Artigo em Inglês | MEDLINE | ID: mdl-21955667

RESUMO

The association of cardiovascular events with Lp-PLA2 has been studied continuously today. The enzyme has been strongly associated with several cardiovascular risk markers and events. Its discovery was directly related to the hydrolysis of the platelet-activating factor and oxidized phospholipids, which are considered protective functions. However, the hydrolysis of bioactive lipids generates lysophospholipids, compounds that have a pro-inflammatory function. Therefore, the evaluation of the distribution of Lp-PLA2 in the lipid fractions emphasized the dual role of the enzyme in the inflammatory process, since the HDL-Lp-PLA2 enzyme contributes to the reduction of atherosclerosis, while LDL-Lp-PLA2 stimulates this process. Recently, it has been verified that diet components and drugs can influence the enzyme activity and concentration. Thus, the effects of these treatments on Lp-PLA2 may represent a new kind of prevention of cardiovascular disease. Therefore, the association of the enzyme with the traditional assessment of cardiovascular risk may help to predict more accurately these diseases.


Assuntos
1-Alquil-2-acetilglicerofosfocolina Esterase/metabolismo , Antioxidantes/metabolismo , Mediadores da Inflamação/metabolismo , Lisofosfolipídeos/metabolismo , 1-Alquil-2-acetilglicerofosfocolina Esterase/antagonistas & inibidores , 1-Alquil-2-acetilglicerofosfocolina Esterase/sangue , 1-Alquil-2-acetilglicerofosfocolina Esterase/química , Animais , Anticolesterolemiantes/uso terapêutico , Aterosclerose/sangue , Aterosclerose/epidemiologia , Aterosclerose/metabolismo , Aterosclerose/prevenção & controle , Humanos , Mediadores da Inflamação/sangue , Lipoproteínas LDL/sangue , Lipoproteínas LDL/metabolismo , Lisofosfolipídeos/sangue , Terapia de Alvo Molecular , Estresse Oxidativo , Fatores de Risco
5.
Toxicon ; 28(2): 215-24, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2339436

RESUMO

The effects of crotoxin, isolated from the venom of the South American rattlesnake, Crotalus durissus terrificus, were investigated on isolated guinea pig hearts, perfused with Locke solution, by the Langendorff method. The cardiac beats and the electrocardiogram were simultaneously registered and the creatine kinase (CK) activity of the perfusate measured. Crotoxin was infused (4.5 x 10(-8) M and 2.3 x 10(-7) M) into the heart during 90 min, and induced a remarkable decrease in the contractile force, without a significant reduction of heart rate, increased the P-R interval and displaced the S-T segment. The activity of CK only increased in the late phases of the experiments, when the force of contraction was below 25% of the control value. Arrhythmias were uncommon and no alterations of QRS duration or Q-Tc interval were observed. The reduction of the contractile force and the increase in CK activity were completely prevented by bovine serum albumin, whereas lanatoside C did not interfere with the toxin action. A bolus injection of crotoxin (11 +/- 2 nmoles) also induced a decrease of contractile force without reduction of heart rate. This decrease of force was partially prevented by indomethacin, but not by atropine. It is suggested that the reduction of contractile force evoked by crotoxin is due probably to release of free fatty acids and lysophospholipids (initial effect) and to a cellular lesion (late effect).


Assuntos
Venenos de Crotalídeos/toxicidade , Crotoxina/toxicidade , Cardiopatias/induzido quimicamente , Coração/efeitos dos fármacos , Albuminas/análise , Animais , Atropina/toxicidade , Creatina Quinase/análise , Eletrocardiografia , Ácidos Graxos não Esterificados/sangue , Feminino , Cobaias , Cardiopatias/enzimologia , Cardiopatias/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Técnicas In Vitro , Indometacina/toxicidade , Lanatosídeos/toxicidade , Lisofosfolipídeos/sangue , Masculino , Contração Miocárdica/efeitos dos fármacos , Miocárdio/enzimologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA